Journal of Cancer Research and Therapeutics Close
 

Figure 2: Liver computed tomography scans (a-d) Before chemotherapy with 1st gemcitabine and nedaplatin administration (July 13, 2019) (e-h) After 2 cycles of gemcitabine and nedaplatin (October 05, 2019) (i-l) Before VEC and apatinib administration (November 21, 2019) (m-p) After 2 cycles of VEC and apatinib (January 17, 2020) (q-t) After 4 cycles of VEC and apatinib (April 20, 2020) (u-x) After 6 cycles of VEC and apatinib (July 30, 2020)

Figure 2: Liver computed tomography scans (a-d) Before chemotherapy with 1<sup>st</sup> gemcitabine and nedaplatin administration (July 13, 2019) (e-h) After 2 cycles of gemcitabine and nedaplatin (October 05, 2019) (i-l) Before VEC and apatinib administration (November 21, 2019) (m-p) After 2 cycles of VEC and apatinib (January 17, 2020) (q-t) After 4 cycles of VEC and apatinib (April 20, 2020) (u-x) After 6 cycles of VEC and apatinib (July 30, 2020)